News
The Gateshead pharmaceutical firm has received an initial payment of $665,000 as part of the exclusive licence agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results